LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report)'s stock price dropped 5.1% during mid-day trading on Monday . The stock traded as low as $5.34 and last traded at $5.36. Approximately 677,437 shares were traded during trading, a decline of 54% from the average daily volume of 1,457,571 shares. The stock had previously closed at $5.65.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the company. Barclays increased their price target on LifeStance Health Group from $7.00 to $8.00 and gave the company an "underweight" rating in a research report on Thursday, February 29th. Morgan Stanley reissued an "overweight" rating and set a $10.00 price target on shares of LifeStance Health Group in a research report on Monday, April 22nd. The Goldman Sachs Group upped their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a "neutral" rating in a research report on Monday, March 4th. Finally, Jefferies Financial Group lifted their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a "buy" rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $8.80.
Check Out Our Latest Stock Report on LifeStance Health Group
LifeStance Health Group Stock Performance
The company's 50-day moving average is $6.24 and its two-hundred day moving average is $6.63. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.20. The company has a market cap of $2.05 billion, a P/E ratio of -11.15 and a beta of 1.24.
LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.03. The firm had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. The company's revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.09) EPS. Equities analysts predict that LifeStance Health Group, Inc. will post -0.27 EPS for the current year.
Insiders Place Their Bets
In related news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the business's stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $5.89, for a total value of $22,395,812.05. Following the sale, the insider now directly owns 41,932,358 shares in the company, valued at approximately $246,981,588.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of LifeStance Health Group stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $5.89, for a total value of $22,395,812.05. Following the completion of the transaction, the insider now directly owns 41,932,358 shares in the company, valued at approximately $246,981,588.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Paula Cipollone sold 48,278 shares of the business's stock in a transaction on Monday, May 13th. The shares were sold at an average price of $7.22, for a total transaction of $348,567.16. Following the sale, the insider now directly owns 239,915 shares in the company, valued at approximately $1,732,186.30. The disclosure for this sale can be found here. Insiders sold 3,910,128 shares of company stock valued at $23,117,200 over the last ninety days. 6.60% of the stock is currently owned by insiders.
Institutional Trading of LifeStance Health Group
Institutional investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its holdings in LifeStance Health Group by 6.7% in the 3rd quarter. FMR LLC now owns 28,178,666 shares of the company's stock valued at $193,587,000 after purchasing an additional 1,758,427 shares during the period. Brown Advisory Inc. grew its position in LifeStance Health Group by 25.9% during the fourth quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company's stock worth $40,395,000 after buying an additional 1,062,887 shares in the last quarter. Rock Springs Capital Management LP increased its stake in LifeStance Health Group by 26.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 3,670,000 shares of the company's stock worth $25,213,000 after acquiring an additional 770,000 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of LifeStance Health Group by 2.8% in the 4th quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company's stock valued at $31,370,000 after acquiring an additional 110,457 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of LifeStance Health Group by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company's stock valued at $47,318,000 after acquiring an additional 95,197 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company's stock.
LifeStance Health Group Company Profile
(Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
See Also
- Five stocks we like better than LifeStance Health Group
- What is Short Interest? How to Use It
- Our Comprehensive Risk Tolerance Assessment
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Autodesk Raises Guidance After Clearing Audit Investigation
- What is a Stock Market Index and How Do You Use Them?
- Lyft Stock Gap and Craps on Bold 2027 Guidance at Investor Day
→ Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad)
Should you invest $1,000 in LifeStance Health Group right now?
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A Guide To High-Short-Interest Stocks
MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
